A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...
Chemotherapy plus local therapy improved overall survival and disease-free survival when compared to local therapy alone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback